Cargando…
Evaluation of visual pathways using visual evoked potential in patients with diabetic retinopathy
Visual evoked potential (VEP) is an electrophysiological exploration to detect the response to light stimulus and reveal visual pathways. Aim: VEP study in patients with diabetes mellitus (DM), assessment of cortical and retinal activity, and identifying the role of this investigation in the diagnos...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Romanian Society of Ophthalmology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943291/ https://www.ncbi.nlm.nih.gov/pubmed/31915735 |
_version_ | 1783484860056207360 |
---|---|
author | Corduneanu, Angela Chişca, Veronica Ciobanu, Natalia Groppa, Stanislav |
author_facet | Corduneanu, Angela Chişca, Veronica Ciobanu, Natalia Groppa, Stanislav |
author_sort | Corduneanu, Angela |
collection | PubMed |
description | Visual evoked potential (VEP) is an electrophysiological exploration to detect the response to light stimulus and reveal visual pathways. Aim: VEP study in patients with diabetes mellitus (DM), assessment of cortical and retinal activity, and identifying the role of this investigation in the diagnosis of diabetic retinopathy. Methods: A case-control study conducted to investigate two groups: the first group (G1) included 78 patients (156 eyes) with different stages of diabetic retinopathy, and the second group (G0) included 78 healthy subjects (156 eyes). All subjects have been ophthalmologically and neurologically tested, also using visual evoked potentials. The patients have been exposed to mono-ocular, non-patterned stimuli, using LED-goggles glasses. Results: A serious increase in P100 and N75 wavelength latency in diabetic patients has been observed when compared to healthy subjects (p<0.05), and a N135 value increase in patients with diabetes mellitus (p=0.06). In addition, the amplitude of the P100 wave has changed in diabetic patients in comparison to healthy subjects. Conclusions: Changes in latency of waves registered on the VEP pathway and the amplitude of the P100 wave have been observed in patients with diabetic retinopathy (89.7%), which proved the importance of this study in the diagnosis of diabetic retinopathy and the possibility to examine the prognosis of this disabling disease. |
format | Online Article Text |
id | pubmed-6943291 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Romanian Society of Ophthalmology |
record_format | MEDLINE/PubMed |
spelling | pubmed-69432912020-01-08 Evaluation of visual pathways using visual evoked potential in patients with diabetic retinopathy Corduneanu, Angela Chişca, Veronica Ciobanu, Natalia Groppa, Stanislav Rom J Ophthalmol General Articles Visual evoked potential (VEP) is an electrophysiological exploration to detect the response to light stimulus and reveal visual pathways. Aim: VEP study in patients with diabetes mellitus (DM), assessment of cortical and retinal activity, and identifying the role of this investigation in the diagnosis of diabetic retinopathy. Methods: A case-control study conducted to investigate two groups: the first group (G1) included 78 patients (156 eyes) with different stages of diabetic retinopathy, and the second group (G0) included 78 healthy subjects (156 eyes). All subjects have been ophthalmologically and neurologically tested, also using visual evoked potentials. The patients have been exposed to mono-ocular, non-patterned stimuli, using LED-goggles glasses. Results: A serious increase in P100 and N75 wavelength latency in diabetic patients has been observed when compared to healthy subjects (p<0.05), and a N135 value increase in patients with diabetes mellitus (p=0.06). In addition, the amplitude of the P100 wave has changed in diabetic patients in comparison to healthy subjects. Conclusions: Changes in latency of waves registered on the VEP pathway and the amplitude of the P100 wave have been observed in patients with diabetic retinopathy (89.7%), which proved the importance of this study in the diagnosis of diabetic retinopathy and the possibility to examine the prognosis of this disabling disease. Romanian Society of Ophthalmology 2019 /pmc/articles/PMC6943291/ /pubmed/31915735 Text en ©Romanian Society of Ophthalmology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | General Articles Corduneanu, Angela Chişca, Veronica Ciobanu, Natalia Groppa, Stanislav Evaluation of visual pathways using visual evoked potential in patients with diabetic retinopathy |
title | Evaluation of visual pathways using visual evoked potential in patients with diabetic retinopathy
|
title_full | Evaluation of visual pathways using visual evoked potential in patients with diabetic retinopathy
|
title_fullStr | Evaluation of visual pathways using visual evoked potential in patients with diabetic retinopathy
|
title_full_unstemmed | Evaluation of visual pathways using visual evoked potential in patients with diabetic retinopathy
|
title_short | Evaluation of visual pathways using visual evoked potential in patients with diabetic retinopathy
|
title_sort | evaluation of visual pathways using visual evoked potential in patients with diabetic retinopathy |
topic | General Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943291/ https://www.ncbi.nlm.nih.gov/pubmed/31915735 |
work_keys_str_mv | AT corduneanuangela evaluationofvisualpathwaysusingvisualevokedpotentialinpatientswithdiabeticretinopathy AT chiscaveronica evaluationofvisualpathwaysusingvisualevokedpotentialinpatientswithdiabeticretinopathy AT ciobanunatalia evaluationofvisualpathwaysusingvisualevokedpotentialinpatientswithdiabeticretinopathy AT groppastanislav evaluationofvisualpathwaysusingvisualevokedpotentialinpatientswithdiabeticretinopathy |